Skip to content

CAPS

Capstone Holding Corp.

NASDAQ · Basic Materials · Construction Materials · US

$2.75
−3.00%
Ask drillr
Price chart
Sep 30Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29
Key dataOct 29, 2026
Open
$2.76
From 52W high
−91.76%
Volume
5830.00
Market cap
$2.52M
P/E (Fwd)
3.0x
EV/EBITDA
−2.4x
P/E (TTM)
—
RSI (14)
29.7
1D Return
−3.00%
YTD Return
−87.32%
SummaryUpdated Jun 1, 2026

Capstone Therapeutics Corp. (NASDAQ:CAPS) is a biotechnology company founded in 1987 and headquartered in Tempe, Arizona. Originally established as OrthoLogic Corp., the company changed its name to Capstone Therapeutics Corp. in May 2010. The company went public in 1993 and has since focused on developing novel peptides and other molecules to address underserved medical conditions. Capstone operates in the competitive biotechnology sector, where companies develop innovative treatments and therapies through extensive research and clinical trials.

Similar companies

Latest newsMore news →